• News
  • SAN DIEGO
  • Technology

Illumina announces personal genome sequencing service

Illumina Inc. (Nasdaq: ILMN) unveiled a service program to provide personal genome sequencing for consumers.

The personal genome sequencing service is performed in Illumina’s recently certified CLIA laboratory utilizing Illumina’s industry leading Genome Analyzer technology.

The offering includes sequencing of an individual’s DNA to 30 times depth, providing information on SNP variation and other structural characteristics of the genome such as insertions, deletions and rearrangements.

Illumina intends to create a social community for the education and exchange of information for those who have had their genomes sequenced. As more information becomes available, participants will be in a position to mine their personal genome sequence data to understand their identity in ways which have never been possible.

In addition to the sequencing service, Illumina is establishing a protocol, infrastructure, and community to enable large-scale adoption of personal genome sequencing. This includes the creation of a network of partners to offer a variety of services. Data analysis partners, physicians and genetic counselors will play an important role in Illumina’s Personal Genome Sequencing Service. A physician’s network is being created as physicians will be critical to the service – to discuss the process with the consumer, order the sequencing service, collect DNA samples and deliver final sequencing data to the consumer.

Illumina is collaborating with a number of partners, including 23andMe, deCODE Genetics, Knome and Navigenics, to encourage secondary data analysis such as calculation of disease risk, ancestry, and information on traits of interest. Genetic counselors will also play a role in counseling individuals on the results.

As part of the CLIA certification process, Illumina sequenced Jay Flatley, CEO and president of Illumina and is currently processing three other individuals’ genomes. Hermann Hauser, Partner, Amadeus Capital Partners Ltd, is the second individual to have his genome sequenced through this service.

Two additional individuals who are being sequenced using Illumina’s Personal Genome Sequencing service include Henry Louis “Skip” Gates, Jr., Alphonse Fletcher University Professor at Harvard and his father Henry Louis Gates, Sr. Skip Gates is the Director of the W.E.B. Du Bois Institute of African and African American Research, has published 12 books, made nine documentary film series and is the Host and co-Executive Producer of “Faces of America”.

Illumina’s Personal Genome Sequencing Service will be offered for $48,000.

User Response
0 UserComments